William R Short, MD, MPH, AAHIVS

faculty photo
Associate Professor of Clinical Medicine
Department: Medicine

Contact information
3910 Powelton Avenue, 411C
Perelman School of Medicine
University of Pennsylvania
Department of Medicine, Division of Infectious Diseases
Philadelphia, PA 19104
Office: 215-662-8693
Education:
Associates (Nursing)
Hahnemann University, School of Allied Health Professions, 1986.
BS
Hahnemann University School of Health Sciences and Professions, 1989.
MD
Hahnemann University School of Medicine, 1997.
MPH (Epidemiology and Health Systems Policy)
UMDNJ School of Public Health, 2009.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Podzamczer D, Arribas JR, Clarke A, Cotte L, Mudrikova T, Negredo E, Short WR, Jiang S, Cheng A, Das M: Adults with renal impairment switching from tenofovir disoproxil fumarate to tenofovir alafenamide have improved renal and bone safety through 144 weeks International AIDS Society (IAS) Meeting, Paris France July 2017.

Coppock D, Short WR: Immune Reconstitution Inflammatory Syndrome. HIV Fundamentals. W. David Hardy (eds.). Oxford Press, 2017 Edition: 537-541, March 2017.

Short WR, Shafer JJ: Antiretroviral Therapy in Pregnant Women. HIV Fundamentals. W. David Hardy (eds.). Oxford Press, 2017 Edition: 291-295, March 2017.

Nambiar P, Short WR: Mechanisms of HIV Transmission. Fundamentals of HIV Medicine. W. David hardy (eds.). Oxford Press, 2017 Edition: 23-26, March 2017.

Post FA, Tebas P, Clarke A, Cotte L, Short WR, Abram ME, Jiang S, Cheng A, Das M, Fordyce MW: Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. J acquir immune defic syndr 74(2): 180-184, Feb 2017.

Short WR, Mofenson L, Tilson H: Is it Safe? Safety Surveillance through the Antiretroviral Pregnancy registry. Webinar Feb 2017.

Short WR: HIV and Pregnancy. Maternal-Fetal Evidence based Guidelines. Vincenzo Berghella (eds.). CRC Press, 3rd Edition: 297, Jan 2017.

Jessica A, Beckerman K, Mofenson L, Pikis A, Scheuerle A, Short WR, Seekins D, Vannappagari V, Tilson H, Watts H: Central Nervous System (CNS) and Neural Tube (NT) Birth Defects in The Antiretroviral Pregnancy Registry (APR). ID Week, New Orleans, LA(147), Oct 2016.

C Martorell, D Ward, W Short, I Brar, M Ramgopal, D Cunningham, J DeMorin7, D Piontkowsky, P Wong, M Das, T Nguyen-Cleary, S McCallister: Efficacy and Safety of Co-formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide in Geriatric Adults with Renal Impairment. 7th International Workshop on HIV & Aging, Washington DC September 2016 Notes: Poster presentation #36.

Rockstroh JK, Post F, Clarke A, Short WR, Cheng A, Das M, Lee K, Fordyce M: Longer Term Safety of Tenofovir Alafenamide in Renal Impairment. First Asia Pacific AIDS & Co-Infections Conference, Hong Kong May 2016 Notes: Poster presentation #70.

back to top
Last updated: 12/12/2017
The Trustees of the University of Pennsylvania